Shenqi particle: A novel therapy for idiopathic membranous nephropathy

摘要

Membranous nephropathy is among the most common causes of nephrotic syndrome in non-diabetic adults. Three-fourths of all cases are idiopathic (IMN), meaning they have no detectable clinical, sero-logic, or histologic evidence of secondary causes. It is recognized that supportive treatment alone leads to complete remission in 5%-30% and partial remission in 25%-40% of patients with IMN 5 years after diagnosis.